Aldeyra Therapeutics (ALDX) director receives new stock option awards
Filing Impact
Filing Sentiment
Form Type
4
Rhea-AI Filing Summary
Aldeyra Therapeutics director Gary M. Phillips received three stock option grants. On the reported date, he was awarded options to buy 70,000, 6,636 and 4,977 shares of common stock at an exercise price of $1.72 per share. Each grant becomes fully exercisable on the one-year anniversary of the grant date, if he continues serving on the Board and its Compensation and Audit Committees as applicable.
Positive
- None.
Negative
- None.
Insider Trade Summary
3 transactions reported
Mixed
3 txns
Insider
Phillips Gary M.
Role
null
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Stock Option (Right to Buy) | 70,000 | $0.00 | -- |
| Grant/Award | Stock Option (Right to Buy) | 6,636 | $0.00 | -- |
| Grant/Award | Stock Option (Right to Buy) | 4,977 | $0.00 | -- |
Holdings After Transaction:
Stock Option (Right to Buy) — 70,000 shares (Direct, null)
Footnotes (1)
- Exercisable with respect to 100% of the shares on the one-year anniversary of the grant date, provided that the Reporting Person provides continuous service as a member of the Board of Directors of the Issuer through the applicable vesting date. Exercisable with respect to 100% of the shares on the one-year anniversary of the grant date, provided that the Reporting Person provides continuous service as a member of the Compensation Committee of the Board of Directors of the Issuer through the applicable vesting date. Exercisable with respect to 100% of the shares on the one-year anniversary of the grant date, provided that the Reporting Person provides continuous service as a member of the Audit Committee of the Board of Directors of the Issuer through the applicable vesting date.
Key Figures
Option grant size: 70,000 options
Option grant size: 6,636 options
Option grant size: 4,977 options
+2 more
5 metrics
Option grant size
70,000 options
Stock Option (Right to Buy) grant, underlying common shares
Option grant size
6,636 options
Stock Option (Right to Buy) grant, underlying common shares
Option grant size
4,977 options
Stock Option (Right to Buy) grant, underlying common shares
Exercise price
$1.72 per share
Conversion or exercise price for each option grant
Expiration date
June 8, 2036
Option expiration for all three grants
Key Terms
Stock Option (Right to Buy), Grant, award, or other acquisition, Compensation Committee, Audit Committee, +1 more
5 terms
Stock Option (Right to Buy) financial
"security_title: Stock Option (Right to Buy)"
Grant, award, or other acquisition financial
"transaction_code_description: Grant, award, or other acquisition"
Compensation Committee financial
"continuous service as a member of the Compensation Committee of the Board"
A compensation committee is a group within a company's leadership responsible for setting and reviewing how much top executives and employees are paid, including salaries, bonuses, and benefits. It matters to investors because fair and effective pay decisions can influence a company's performance, leadership motivation, and overall governance, helping ensure that the company’s management is aligned with shareholders’ interests.
Audit Committee financial
"continuous service as a member of the Audit Committee of the Board"
A company's audit committee is a small group of board members who act like independent inspectors for the firm's finances, overseeing how financial reports are prepared, monitoring internal controls, and managing the relationship with external auditors. Investors care because a strong audit committee reduces the risk of accounting errors, fraud, or misleading statements, making financial statements more trustworthy and helping protect shareholder value.
continuous service financial
"provided that the Reporting Person provides continuous service as a member"
FAQ
What did Aldeyra Therapeutics (ALDX) director Gary M. Phillips report on this Form 4?
Gary M. Phillips reported receiving three stock option grants. These options give him the right to buy Aldeyra common stock at a fixed price, reflecting equity-based compensation for his service on the Board and its key committees.
How many Aldeyra Therapeutics stock options were granted to Gary M. Phillips?
He was granted options on 70,000, 6,636 and 4,977 underlying shares of common stock. Each grant represents a separate award tied to his role on the Board of Directors and specific committees at Aldeyra Therapeutics.
What is the exercise price of the Aldeyra Therapeutics options granted to Gary M. Phillips?
All three option grants carry an exercise price of $1.72 per share. This means Phillips can purchase Aldeyra common stock at $1.72 if and when the options vest and he chooses to exercise them before expiration.
When do Gary M. Phillips’ Aldeyra stock options vest according to the Form 4?
Each option grant becomes exercisable with respect to 100% of the shares on the one-year anniversary of the grant date. Vesting requires that Phillips continue to serve on the Board or relevant committee through the applicable vesting date.
What roles are tied to Gary M. Phillips’ Aldeyra Therapeutics option vesting conditions?
The vesting conditions reference his continuous service as a member of the Board of Directors, the Compensation Committee and the Audit Committee. Each grant relates to one of these roles and vests fully after one year of qualifying service.
When do the Aldeyra Therapeutics stock options granted to Gary M. Phillips expire?
Each option grant has an expiration date of June 8, 2036. After that date, any unexercised options will lapse, so Phillips must exercise vested options before that expiration to purchase Aldeyra common shares at the grant price.